Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Aripiprazole NDC 82804-023 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure - aripiprazole fig1

figure - aripiprazole fig1

82804-023-30 - aripiprazole fig12

82804-023-30 - aripiprazole fig12

figure - aripiprazole fig2

figure - aripiprazole fig2

figure - aripiprazole fig3

figure - aripiprazole fig3

figure - aripiprazole fig4

figure - aripiprazole fig4

figure - aripiprazole fig5

figure - aripiprazole fig5

Figure 6: Kaplan-Meier Estimation of Cumulative Proportion of patients with Relapse (Schizophrenia Study 5) - aripiprazole fig6

Figure 6: Kaplan-Meier Estimation of Cumulative Proportion of patients with Relapse (Schizophrenia Study 5) - aripiprazole fig6

Figure 6 shows the Kaplan-Meier estimation of the cumulative proportion of patients with relapse in Schizophrenia Study 5. The figure includes data for both the Aripiprazole and Placebo groups. The x-axis represents the number of days from randomization, and the y-axis represents the proportion of patients with relapse. The data consists of the number of subjects at risk for relapse at each time point for both the Aripiprazole and Placebo groups.*

Figure 9: Least Square Means of Change from Baseline in YGTSS TTS by Week (Tourette’s Disorder Study 1) - aripiprazole fig7

Figure 9: Least Square Means of Change from Baseline in YGTSS TTS by Week (Tourette’s Disorder Study 1) - aripiprazole fig7

This text appears to be a chart or graph showing the change in YGTSS (Yale Global Tic Severity Scale) total TIC score over time, specifically comparing the effect of low dosage and high dosage of a medication called Aripiprazole, as well as a placebo. The chart displays the number of weeks of treatment on the X-axis and the change in the YGTSS total TIC score on the Y-axis. The values in the chart indicate that there was no change at week 0, a decrease of 5 at week 1, and no change again at week 2 and 4. The specific nature of the change or the study is not clear from the given text.*

Aripiprazole Structure - aripiprazole str

Aripiprazole Structure - aripiprazole str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.